Exceptional Potential
Exceptional Value
Exceptionally Risky
Recent Posts


26 Oct BriaCell Announces the Appointment of Biotechnology Veteran William Williams as New CEO and Director

BriaCell Therapeutics Corp., a clinical-stage immuno-oncology company dedicated to the development of immuno-oncology treatments that can enhance the lives of cancer patients, is pleased to announce the appointment of Dr. William Williams, as its President, CEO and a member of the Board of Directors effective...

Read More